B Martin

Summary

Affiliation: Institut Jules Bordet
Country: Belgium

Publications

  1. pmc Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
    B Martin
    Laboratoire d Investigation Clinique H J Tagnon, Departement de Medecine, Institut Jules Bordet Brussels, Belgium
    Br J Cancer 89:55-64. 2003
  2. ncbi Expression of p53 in preneoplastic and early neoplastic bronchial lesions
    B Martin
    Service de Medecine, Institut Jules Bordet, B 1000 Brussels, Belgium
    Oncol Rep 9:223-9. 2002
  3. pmc Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
    B Martin
    Critical Care Department and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, Brussels, Belgium
    Br J Cancer 91:2018-25. 2004
  4. pmc Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
    C Mascaux
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, B 1000 Brussels, Belgium
    Br J Cancer 95:139-45. 2006
  5. ncbi The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
    A P Meert
    Dept of Internal Medicine, Jules Bordet Institute, Brussels, Belgium
    Eur Respir J 20:975-81. 2002
  6. ncbi EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions
    A P Meert
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
    Anticancer Res 26:135-8. 2006
  7. ncbi Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis
    T Berghmans
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, Belgium
    Ann Oncol 17:1673-6. 2006
  8. pmc The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
    A P Meert
    Département de Médecine Interne et Laboratoire d Investigation Clinique et d Oncologie Expérimentale HJ Tagnon, Institut Jules Bordet, Bruxelles, Belgium
    Br J Cancer 87:694-701. 2002
  9. ncbi Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: a preliminary study
    A P Meert
    Départment de Médicine Interne et Laboratoire d Investigation Clinique et d Oncologie Expérimentale HJ Tagnon, Institut Jules Bordet, Brussels, Belgium
    Histopathology 44:47-53. 2004
  10. ncbi Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
    T Berghmans
    Dept of Critical Care and Thoracic Oncology, Institut Jules Bordet, Rue Heger Bordet 1, 1000 Bruxelles, Belgium
    Eur Respir J 25:329-35. 2005

Collaborators

Detail Information

Publications31

  1. pmc Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
    B Martin
    Laboratoire d Investigation Clinique H J Tagnon, Departement de Medecine, Institut Jules Bordet Brussels, Belgium
    Br J Cancer 89:55-64. 2003
    ..26 (0.58-2.72) for three studies on neuroendocrine tumours. In NSCLC, Bcl-2 expression was associated with a better prognosis. The data on Bcl-2 expression in small cell lung cancer were insufficient to assess its prognostic value...
  2. ncbi Expression of p53 in preneoplastic and early neoplastic bronchial lesions
    B Martin
    Service de Medecine, Institut Jules Bordet, B 1000 Brussels, Belgium
    Oncol Rep 9:223-9. 2002
    ..The alteration of p53 expression in patients with high risk of lung cancer was an early event: this abnormality increased with the severity of the lesions, without significant correlation with patient characteristics...
  3. pmc Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
    B Martin
    Critical Care Department and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, Brussels, Belgium
    Br J Cancer 91:2018-25. 2004
    ..56 (95% CI: 1.30-1.87), showing a worse survival when Ki-67 expression is increased. In conclusion, our meta-analysis shows that the expression of Ki-67 is a factor of poor prognosis for survival in NSCLC...
  4. pmc Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
    C Mascaux
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, B 1000 Brussels, Belgium
    Br J Cancer 95:139-45. 2006
    ..This effect is statistically significant in stage I, suggesting that COX-2 expression could be useful at early stages to distinguish those with a worse prognosis...
  5. ncbi The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
    A P Meert
    Dept of Internal Medicine, Jules Bordet Institute, Brussels, Belgium
    Eur Respir J 20:975-81. 2002
    ..Epidermal growth factor receptor might be a poor prognostic factor for survival in nonsmall-cell lung cancer. The amplitude of the impact is small, however, and may be subject to publication bias...
  6. ncbi EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions
    A P Meert
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
    Anticancer Res 26:135-8. 2006
    ..The relationships between EGF-R and c-erbB-2 with other factors involved in tumour regulation are not well understood. The aim of this study was to correlate the expression of these markers with tumour proliferation...
  7. ncbi Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis
    T Berghmans
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, Belgium
    Ann Oncol 17:1673-6. 2006
    ..The aim of this study was to determine the prognostic role for survival of thyroid transcription factor 1 (TTF-1) in lung cancer...
  8. pmc The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
    A P Meert
    Département de Médecine Interne et Laboratoire d Investigation Clinique et d Oncologie Expérimentale HJ Tagnon, Institut Jules Bordet, Bruxelles, Belgium
    Br J Cancer 87:694-701. 2002
    ..Microvessel count, reflecting the angiogenesis, appears to be a poor prognostic factor for survival in surgically treated non small cell lung cancer but standardisation of angiogenesis assessment by the microvessel count is necessary...
  9. ncbi Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: a preliminary study
    A P Meert
    Départment de Médicine Interne et Laboratoire d Investigation Clinique et d Oncologie Expérimentale HJ Tagnon, Institut Jules Bordet, Brussels, Belgium
    Histopathology 44:47-53. 2004
    ..The aim of this study was to assess the proliferative activity of mild (MiD), moderate (MoD), severe (SD) dysplasia and carcinoma in situ (CIS) by the expression of Ki67 on biopsy specimens obtained during fluorescence bronchoscopy...
  10. ncbi Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
    T Berghmans
    Dept of Critical Care and Thoracic Oncology, Institut Jules Bordet, Rue Heger Bordet 1, 1000 Bruxelles, Belgium
    Eur Respir J 25:329-35. 2005
    ....
  11. ncbi Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGFR expression
    A P Meert
    Département de Soins Intensifs et Oncologie Thoracique, Institut Jules Bordet, Bruxelles, Belgium
    Histopathology 50:311-7. 2007
    ..Also, to correlate MVC with epidermal growth factor receptor (EGFR) expression...
  12. pmc Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
    A P Meert
    Service de Medecine, Institut Jules Bordet, Bruxelles, Belgique
    BMC Cancer 1:5. 2001
    ..A systematic review of the literature was carried out to determine the role of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC)...
  13. ncbi Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer
    T Berghmans
    Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Bruxelles, Belgium
    Lung Cancer 52:219-24. 2006
    ..Forty-four patients were positive for TTF-1 (squamous 25.0% versus non-squamous 55.4%). In multivariate analysis, only three factors were statistically significantly associated with better survival: good PS, surgery and creatinine level...
  14. ncbi COX-2 expression during early lung squamous cell carcinoma oncogenesis
    C Mascaux
    Dept of Intensive Care and Thoracic Oncology, CHU Saint Pierre, Brussels, Belgium
    Eur Respir J 26:198-203. 2005
    ..Thus, cyclooxygenase-2 appears as a potential early marker of squamous cell carcinoma...
  15. pmc The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
    C Mascaux
    Department of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l Universite Libre de Bruxelles, Belgium
    Br J Cancer 92:131-9. 2005
    ..40; 95% CI 1.18-1.65) but not in studies using IHC (HR 1.08; 95% CI 0.86-1.34). RAS appears to be a pejorative prognostic factor in terms of survival in NSCLC globally, in ADC and when it is studied by PCR...
  16. ncbi Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53
    C Mascaux
    Dept of Internal Medicine and Laboratory of Clinical Investigation and Experimental Oncology, Jules Bordet Institute, Brussels, Belgium
    Eur Respir J 21:753-8. 2003
    ..The results suggest that for fragile histidine triad, the pathway of tumourigenesis is independent of p53 and of tumoural proliferation, as reported previously in vitro...
  17. doi The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma
    C Mascaux
    Dept of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, B 1000 Brussels, Belgium
    Eur Respir J 32:678-86. 2008
    ..The demonstration of this hypothesis requires further functional studies...
  18. ncbi Expression of thrombospondin in non-small cell lung cancer
    C Mascaux
    Department of Medicine Institut Jules Bordet, Brussels, Belgium
    Anticancer Res 22:1273-7. 2002
    ..The secondary objectives were to investigate its relationship with other factors related to angiogenesis and to assess their clinicopathological significance. Materials and..
  19. pmc The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
    A P Meert
    Fonds National de la Recherche Scientifique, Bruxelles, Belgium
    Br J Cancer 89:959-65. 2003
    ....
  20. ncbi [EGF-R expression correlation between biopsy and surgical specimens of lung carcinoma]
    A P Meert
    FNRS Fonds National de la Recherche Scientifique, Institut Jules Boerdet, Bruxelles, Belgique
    Rev Mal Respir 20:347-53. 2003
    ..New approaches in non small cell lung cancer (NSCLC) treatment consist to administer neoadjuvant chemotherapy or anti-EGF-R (epidermal growth factor receptor) drug...
  21. doi The galectin family and digestive disease
    P Demetter
    Department of Pathology, Erasme University Hospital, Universite Libre de Bruxelles ULB, Brussels, Belgium
    J Pathol 215:1-12. 2008
    ..However, the concretization of these potential modalities requires substantial improvements in terms of standardization of galectin expression evaluation together with prospective validation of the present data...
  22. ncbi Complexed PSA performance for prostate cancer detection in an African-American population
    B Martin
    Louisiana State University Medical Center, New Orleans, Louisiana 70112, USA
    Urology 62:835-9. 2003
    ..We sought to evaluate the diagnostic performance of cPSA relative to tPSA in a population of African-American men...
  23. ncbi Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions
    A P Meert
    Fond National de la Recherche Scientifique, Dept of Internal Medicine and Laboratoire d Investigation Clinique et d Oncologie Expérimentale HJ Tagnon, Jules Bordet Institute, Bruxelles, Belgium
    Eur Respir J 21:611-5. 2003
    ....
  24. ncbi [VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]
    P Delmotte
    Département de Médecine et Laboratoire d Investigation, Clinique H J Tagnon, France
    Rev Mal Respir 19:577-84. 2002
    ..In conclusion the expression of VEGF in MSCLC is a factor indicating a poor prognosis...
  25. ncbi Paediatric cervical spine injuries
    B Martin
    Emergency Department, Hope Hospital, Stott Lane, Salford M6 8HD, UK
    Injury 36:14-20. 2005
  26. ncbi Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes
    M Bergel
    Protein Section, Division of Basic Science, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 275:11514-20. 2000
    ..Thus, p300 may affect chromatin-related activities not only by modifying histones or transcription factors but also by targeting structural nonhistone proteins...
  27. doi Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study
    Catherine J Wedderburn
    Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK
    Lancet Neurol 7:223-30. 2008
    ..We aimed to test whether outcome differs between adults who had interventional AVM treatment and those who did not...
  28. ncbi [Multiple jejunal strictures caused by gastric heterotopia]
    S Houissa-Vuong
    Cabinet d'Anatomie et de Cytologie Pathologiques, 11 rue Nicolas-Fortin, 75013 Paris, France
    Ann Chir 126:70-4. 2001
    ....
  29. pmc Head injury outcome prediction in the emergency department: a role for protein S-100B?
    W J Townend
    Emergency Department, Hope University Hospital, Salford, UK fs1 ho man ac uk
    J Neurol Neurosurg Psychiatry 73:542-6. 2002
    ..If the serum level of a marker were found to be related to outcome, then earlier identification and intervention would be possible...
  30. ncbi [Surgical management of rectovaginal septum endometriosis from a continuous series of 50 cases]
    O Camagna
    Service de Gynecologie Obstetrique, Hopital Bichat Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France
    Gynecol Obstet Fertil 32:199-209. 2004
    ....
  31. ncbi Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes
    O De Backer
    Ludwig Institute for Cancer Research, Belgium
    Genomics 28:74-83. 1995
    ..Smage1/2 transcripts were detected in several tumor and embryonal cell lines but not in normal mouse tissues with the exception of testis. Expression of Smage3 was found in embryos from Day 11 to Day 15...